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1. Introduction 
5’-Deoxy-S’Shobutyl-thioadenosine (SIBA) was 
synthesized as in [ I] for the purpose of providing a 
biologically active analogue of the endogenous trans- 
methylase inhibitor, AdoHcy [2]. SIBA has been 
shown to exert numerous biological effects which 
include antiviral, oncostatic, antimitotic and antipara- 
sitic activities (review [3]). However, the mechanism(s) 
of action of this structural analogue of AdoHcy still 
remain(s) obscure. SIBA is an inhibitor of tRNA 
methylation and some protein methyltransferases, 
but is a weak inhibitor of these enzymes in vitro 
[4,5]. Cellular transport of nucleosides and sugar is 
inhibited by SIBA, suggesting interaction with mem- 
brane components [6]. A membrane site of action is 
also indicated by the finding that this agent stimulates 
membrane-bound adenylate cyclase in Xenopus Zaevis 
oocytes [7]. 
Several papers have been published on the func- 
tion of SIBA as a substrate for the enzyme responsible 
for the metabolic degradation of MTA, namely MTA 
phosphorylase [8-lo]. In the light of these reports 
we investigated the effect of SIBA on the disposition 
of endogenous MTA by isolated rat hepatocytes. The 
amount of cellular MTA increased in the presence of 
SIBA, and the increase was associated with export of 
MTA from the cells into the extracellular medium. 
Abbreviations: Hepes, N-2-hydroxyethylpiperazine N’-2- 
ethane-sulfonic acid; SIBA, S’deoxy-S’S-isobutyl-thioadeno- 
sine; MTA, 5’-methylthioadenosine (S’deoxy-S’S-methyl- 
thioadenosine); AdoHcy, S-adenosyl-L-homocysteine; 
AdoMet, S-adenosyl-L-methionine 
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2. Experimental 
2.1. Materials 
Sources of most reagents used are in [ 111. 
PBondapak Cl8 column (30 X 0.39 cm) was purchased 
from Waters Associates. ODS Hypersil 3 pm micro- 
particle medium for reverse-phase chromatography 
was from Shandon Southern Products and micropar- 
title medium for cationexchange chromatography, 
Partisil 10 SCX, from HPLC technology. ODS Hypersil 
columns (0.5 X 10 cm, 9000-11 000 theoretical 
plates) and Partisil 10 SCX columns (0.46 X 25 cm) 
were packed by Dr Solheim at our institute, using a 
Shandon column packer. 
2.2. High-pressure liquid chromatography 
Reverse-phase liquid chromatography was per- 
formed on either a PBondapak Cl 8 column, or a ODS 
Hypersil column, which were eluted isocratically at 
ambient temperature at a flow rate of 2 ml/min or 
1 ml/m@ respectively. The ODS Hypersil column 
was eluted in a constant pressure mode. The mobile 
phases were 7-l 2% acetonitril or 20-25% methanol 
in 9 mM potassium phosphate buffer (pH 6.0). 
A Partisil 10 SCX column was used for cation- 
exchange chromatography. The column was eluted 
isocratically at a flow rate of 1.5 ml/min. The mobile 
phases were 210-600 mM ammonium formate buffer, 
pH 2.6,3.5 and 4.0, and all buffers contained 1% iso- 
propanol, which somewhat improved the efficiency 
of the column. 
The solvent delivery system was a Spectra-Physics 
model SP 8OOOB liquid chromatograph. The absorb- 
ance of the effluent was recorded at 254 nm, using a 
Spectra-Physics UVdetector, model SP 8300. 
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2.3. Preparation and incubation of isolated mr 
heparocyres 
Hepatocytes were prepared by a slight modifica- 
tion [ 123 of the collagenase perfusion method [ 131. 
The cells were incubated in an isotonic salt solution 
containing bovine serum albumin and antibiotics, as 
in [l I]. The temperature was 37’C. 
2.4. Determination of cellularMTA 
Samples of 1.5 ml from the cell suspension 
(4:4 X lo6 cells/ml) were centrifuged at 9000 X g for 
15 s in a Beckman type B microfuge, the supernatant 
carefully removed by suction, and the cell-pellet 
immediately homogenized in 150 ~1 icecold, 5% 
sulfosalicyclic acid. The homogenate was centrifuged 
for 5 min at 100 000 X g, using a Beckman Air-fuge. 
The supernatant was immediately neutralized to pH 7 
by addition of 2 N Tris. The neutralized extracts were 
stored at -8O”C, and analyzed by HPLC on a ODS 
Hypersil column within 12 h. The injection volume 
was 204. 
2.5 . Determination of ex tracellular MTA 
Samples of 225 fi from the extracellular medium 
(from which the cells had been removed by centrifu- 
gation) were mixed with 25 /.d of 50% sulfosalicylic 
acid. The extracts were processed and analyzed as in 
section 2.4. 
3. Results 
3.1. Identification and measurement ofMTA in 
heparocyres exposed to SIBA 
Hepatocytes exposed to SIBA accumulated 
UV-absorbing material which showed the same reten- 
tion time as MTA on a MBondapak Cl 8 column 
(fig.1 A-C). This material was separated into 2 distinct 
peaks on a ODS Hypersil column. The compound 
eluting at the lowest retention time (6.83 min) is 
referred to as compound X, and the second peak 
(retention time 7.22 min) co-chromatographed exactly 
with MTA (fig.lD-F). 
Compound X was clearly separated from AdoHcy, 
AdoMet, adenosine, adenine and SIBA by reverse- 
phase chromatography on a ODS Hypersil column. 
The other compound cochromatographed xactly 
with MTA on the ODS Hypersil column eluted with 
various concentrations of acetonitril(7-12%) or 
methanol (20-25%) in phosphate buffer (pH 6.0) 
(not shown). The effluent corresponding to this mate- 
rial was collected, lyophilized, and rechromatographed 
on a Partisil 10 SCX column. The MTA standard and 
the compound showed the same retention times in 
systems with the following mobile phases: 600 mM 
ammonium formate (pH 2.6) (retention time 
8.56 min), 600 mM ammonium formate (pH 3.5) 
(4.33 min) and 210 mM ammonium formate (pH 4.0) 
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Fig.1. Reverse-phase liquid chromatographic analysis of MTA 
in extract from hepatocytes exposed to SIBA. MTA standard 
(A,D), extract from hepatocytes not exposed to SIBA (B,E) 
and extract from hepatocytes (4.4 x lo6 cells/ml) incubated 
with 400 NM SIBA for 10 min (C,F) were analyzed on a 
IBondapak Cl 8 column (A-C) or a ODS Hypersil column 
(D-F). The injectionvolumes were 50 ~1 bBondapak column) 
or 20 pl (ODS Hypersil column). The chromatographic analy- 
sis was otherwise performed as in section 2. The mobile phase 
was 10% acetonitril in 9 mM potassium phosphate buffer 
(pH 6.0). 
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(4.71 mm). Based on these data, it is concluded that 
MTA accumulates in hepatocytes exposed to SIBA. 
Among the chromatographic systems tested, only 
reverse-phase chromatography on ODS Hypersil 
separated MTA from compound X and other inter- 
ferring substances present in extract from hepato- 
cytes exposed to SIBA. 
3.2. Accumulation of MTA in rat hepatocytes 
The amount of MTA in hepatocytes not exposed 
to SIBA was below the detection limit of the method 
used. Cellular-associated MTA increased in a dose- 
dependent manner in hepatocytes incubated with 
SIBA. The MTA-level increased for a few minutes, 
and then declined (fig.2A). In contrast, the cellular 
content of compound X progressively increased for at 
least 40 mm (not shown). 
3.3. Egress of MTA from rat hepatocytes 
Increase in cellular level of MTA was associated 
with a massive secretion of MTAinto the extracellular 
medium. The amount of extracellular MTA increased 
as a function of the concentration of SIBA and time 
of incubation (fig2B). The total amount of MTA 
secreted into the medium was one order of magnitude 
higher than the amount associated with the cells (fig.2). 
A I D 
E 
I 
I 1 
10 0 5 
Retention time ( minutes ) 
Fig.2. Disposition of MTA by isolated hepatocytes exposed to various concentrations of SIBA: (A) amount of MTA associated 
with the hepatocytes (4.4 X lo6 cells/ml); (B) [MTA] in the extracellular medium. The initial concentrations of SIBA added to 
the cell suspensions were 50 MM(~), 100 PM (qo), 200 PM (A,n) and 400 I.~M (*,o). 
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Only trace amounts of compound X were detected in 
the medium, even after 40 min of incubation with 
400 PM SIBA (not shown). 
4. Discussion 
This is the first report on perturbation of MTA 
metabolism by SIBA in intact cells. The increase in 
cellular content of MTA induced by SIBA (fig.2) is in 
accordance with the observation that SIBA is a sub- 
strate for MTA phosphorylase [8-lo]. MTA and 
SIBA are probably competing substrates for this 
enzyme in rat hepatocytes, and SIBA may reduce the 
capacity of the metabolic pathway leading to degra- 
dation of MTA, beyond the rate of production of this 
metabolite. 
The amount of MTA secreted into the extracellular 
medium by hepatocytes exposed to SIBA, far exceeds 
the amount retained within the cells (fig.2). A pro- 
nounced egress of MTA from cultured human leukemic 
cells lacking MTA phosphorylase has been described 
[14]. Furthermore, the rate of uptake of extracellular 
MTA by human lymphocytes is low [ 151. Thus, the 
disposition of MTA by intact cells shows imilarities 
with cellular handling of another thio-ether compound, 
namely AdoHcy. AdoHcy is secreted into the extra- 
cellular medium by rat hepatocytes and some cultured 
cells when the metabolic degradation of this metabo- 
lite is blocked by 9$-Darabinofuranosyladenine [ 161. 
Extracellular AdoHcy is not taken up by intact cells 
[ 11 ,171 and an unidirectional transport of AdoHcy 
has been suggested [ 181, Cellular transport of S-aden- 
osylamino acids and related compounds obviously 
deserves further attention. 
MTA is a product formed from AdoMet during 
polyamine-synthesis [ 191. MTA is a potent inhibitor 
of spermine synthase from bovine brain [20]. Some 
AdoMet-dependent transmethylation reactions are 
inhibited by MTA in vitro [21], and methylation of 
DNA in E. coli is in fact more sensitive to MTA than 
to AdoHcy [22]. MTA also exerts a growth inhibitory 
effect on human lymphocytes [ 151 and SV-3T3 fibro- 
blasts [23]. One may speculate whether at least some 
effects of SIBAin biological systems [3] are mediated 
by MTA. This possibility is somewhat reinforced by 
the observation that the concentrations of SIBA 
inducing detectable increase in cellular content of 
MTA (fig.2) equal those required to obtain biological 
effects of SIBA [3]. 
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